Celliant is a medical-grade technology engineered for better sleep.
As an innovative coating on fabrics and textiles, Celliant is clinically proven to enhance tissue oxygen levels and therefore improve sleep quality and wellness. This natural, organic process improves circulation resulting in higher tissue oxygenation, on average, of 7%, which is conducive to rest and recovery.
The health-giving benefits can be broken down into four simple steps.
Currently, CELLIANT® is designated as a Class 1 Medical Device in Australia, New Zealand, Canada, the European Union, the United Kingdom, Japan, New Zealand and the United Arab Emirates. CELLIANT® is cleared to market in China, India, Indonesia, Korea, Mexico, Peru, Philippines, Singapore, Taiwan, Thailand and Vietnam, with more countries and regions to follow. In the USA, The FDA has determined that CELLIANT® products are medical devices as defined in section 201(h) of the Federal Food, Drug and Cosmetic Act and are general wellness products. However, the FDA has not approved or designated CELLIANT® products for any purpose and has not made any determination about, or endorsement of, its stated use or benefits.
To date, ten clinical trials involving Celliant have taken place across North America.
Effect of CELLIANT® Armbands on Grip Strength in Grip Strength in Subjects with Chronic Wrist and Elbow Pain
Long Beach VA Memorial Hospital
Research Journal of Textile and Apparel
Improved grip strength
Effect of Shirts with 42% CELLIANT® Fiber on tcPO2 Levels and Grip Strength in Healthy Subjects: A Placebo-Controlled Clinical Trial
Long Beach VA Memorial Hospital
Journal of Textile Science and Engineering
Improved grip strength of over 12% in the dominant hand after 90 minutes
Randomized Controlled Trial Comparing the Effects of Far-Infrared Emitting Ceramic Fabric Shirts and Control Polyester Shirts on Transcutaneous PO2
Long Beach VA Memorial Hospital
Journal of Textile Science and Engineering
Average increase in TCPO2 of 8.4% after 90 minutes for 71% of the subjects
The Test Report on the Impacts of Subject Socks with the Application of CELLIANT® Technical Fibers on Transcutaneous Oxygen Pressure on a Man’s Foot
Academy of Chinese Sciences
N/A
Increase in TCPO2 across all healthy subjects
Transcutaneous Partial Pressure of Oxygen (tcPO2) as a Primary Endpoint to Assess the Efficacy of CELLIANT® as a Vasoactive Material
Long Beach VA Memorial Hospital
N/A
An average increase of 7% in TCPO2
Apparel with Far Infrared Radiation for Decreasing an Athlete’s Oxygen Consumption During Submaximal Exercise
University of Calgary
Research Journal of Textile and Apparel
Elite/club cyclists VO2 reduced by 1.1%, increasing anaerobic threshold
Double Blind, Placebo Controlled, Crossover Trial on the Effect of Optically Modified Polyethylene Terephthalate Fiber Mattress Covers on Sleep Disturbances in Patients with Chronic Back Pain
University of CA Irvine
N/A
Nighttime awakenings, sleep quality and sleep efficiency improved
Effect of Optically Modified Polyethylene Terephthalate Fiber Socks on Chronic Foot Pain
University of CA Irvine
BioMed Central Complementary & Alternative Medicine
Statistically significant reduction of pain and improved comfort for subjects (diabetic/foot neuropathy)
Holofiber Study of Thirteen (13) Healthy Subjects
University of Texas A&M
N/A
An average increase in TCPO2 levels from 10% to 24%
Improving Blood Flow with Holofiber in the Hands and Feet of High-Risk Diabetics
Loyola University Chicago
N/A
An average increase in TCPO2 levels from 12% in the hands and 8% in the feet of diabetic subjects
Subscribe
